United States · 
Who invested in Versatope Therapeutics?
Versatope Therapeutics's investors include MassChallenge, MassVentures and National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Versatope Therapeutics
Funding summaryUpdated 26 Oct 2026
$200Kraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $200KMay 2025
- Investors
- 3
The rounds
- May 2025Grant$200K
Source recorded
Founders and team
From Versatope Therapeutics's own website: 2 on the team.
- Alan BarberChief Financial Officer
- Tim MyottHead of Quality Assurance
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Versatope Therapeutics
How much has Versatope Therapeutics raised?
Versatope Therapeutics has raised $200K across 1 round since 2025.
When did Versatope Therapeutics last raise?
Versatope Therapeutics's most recent round was a Grant of $200K in May 2025.
What was Versatope Therapeutics's biggest round?
Its most recent round, $200K in May 2025, is also its largest on record.
Who backed Versatope Therapeutics first?
Versatope Therapeutics's first round on record, in May 2025, was backed by MassChallenge, MassVentures and National Institute of Allergy and Infectious Diseases.
What stage is Versatope Therapeutics at?
Versatope Therapeutics's latest named round is a Grant, in May 2025.
Where is Versatope Therapeutics based?
Versatope Therapeutics is based in the United States.
Companies like Versatope Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.